Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...
Datroway significantly improves overall and progression-free survival in metastatic triple-negative breast cancer patients ineligible for immunotherapy. TROPION-Breast02 trial results highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback